Anna Pratima Ganpat Nikalje
Anna Pratima Ganpat Nikalje has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Mangesh Ghodke
2 shared publicationsVishnu P. Choudhari
Maharashtra Institute of Pharmacy
2 shared publicationsAmol Girbane
Department of Pharmaceutical Chemistry, Y.B. Chavan College of Pharmacy, Aurangabad (M.S.), India
1 shared publicationB Udaykumar Rao
Rauza Bagh, Aurangabad, India
1 shared publicationF Maqdoom
Rauza Bagh, Aurangabad, India
1 shared publicationFiroz Kalam Khan
1 shared publication
Latest Publications
- 1 November 2011
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 46 (11) , 5448-5455
Design and synthesis of 2-(1, 3-dioxoisoindolin-2-yl)-N-(4-oxo-2-substitutedthiazolidin-3-yl) acetamide derivatives as potential anticonvulsant agents
- 1 November 2011
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 46 (11) , 5448-5455
Design and synthesis of 2-(1, 3-dioxoisoindolin-2-yl)-N-(4-oxo-2-substitutedthiazolidin-3-yl) acetamide derivatives as potential anticonvulsant agents
- 23 September 2011
- Published by Wiley in Archiv der Pharmazie
- Vol. 345 (1) , 57-64
Design and Synthesis of Novel Diphenyl Oxalamide and Diphenyl Acetamide Derivatives as Anticonvulsants
A series of novelN1‐substituted‐N2,N2‐diphenyl oxalamides3a–lwere synthesized in good yield by stirring diphenylcarbamoyl formyl chloride (2) and various substituted aliphatic, alicyclic, aromatic, heterocyclic amines in DMF and K2CO3. Also 2‐substituted amino‐N,N‐diphenylacetamides5a–mwere designed by pharmacophore generation and synthesized by stirring 2‐chloro‐N,N‐diphenylacetamide (4) and various substituted amines in acetone using triethyl amine as a catalyst. All the synthesized compounds were screened for anticonvulsant activity in Swiss albino mice by MES and ScPTZ induced seizure tests. Neurotoxicity screening and behavioral testing was also carried out. Some of the synthesized test compounds were found to be more potent than the standard drug.
- 23 September 2011
- Published by Wiley in Archiv der Pharmazie
- Vol. 345 (1) , 57-64
Design and Synthesis of Novel Diphenyl Oxalamide and Diphenyl Acetamide Derivatives as Anticonvulsants
A series of novelN1‐substituted‐N2,N2‐diphenyl oxalamides3a–lwere synthesized in good yield by stirring diphenylcarbamoyl formyl chloride (2) and various substituted aliphatic, alicyclic, aromatic, heterocyclic amines in DMF and K2CO3. Also 2‐substituted amino‐N,N‐diphenylacetamides5a–mwere designed by pharmacophore generation and synthesized by stirring 2‐chloro‐N,N‐diphenylacetamide (4) and various substituted amines in acetone using triethyl amine as a catalyst. All the synthesized compounds were screened for anticonvulsant activity in Swiss albino mice by MES and ScPTZ induced seizure tests. Neurotoxicity screening and behavioral testing was also carried out. Some of the synthesized test compounds were found to be more potent than the standard drug.
- Open Access
- 1 December 2009
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Journal of the Chilean Chemical Society
- Vol. 54 (4) , 424-427
DETERMINATION OF GABAPENTIN IN BULK DRUG AND IN PHARMACEUTICAL DOSAGE FORM BY HPLC METHOD
This paper describes validation of the selective, precise and accurate isocratic HPLC method for the assay of Gabapentin as bulk and pharmaceutical dosage forms. The mobile phase composition was ammonium dihydrogen orthophosphate buffer and methanol in 60:40(v/v) proportions Column used was strong cation exchange column bonded with phenyl sulphonic acid. Quantitation was achieved by UV detection at 200 nm. A linear response (r² ≥ 0.999) was observed in the range of 2.5 mg/mL -7.5 mg/mL. The method shows good recoveries (Average 101.2%) and the relative standard deviation intra and inter-day were found to be less than 0.5 %. Validation parameters were also determined. The method can be used for quality control assay of Gabapentin as bulk and in fnished dosage form and for the stability studies as the method separates Gabapentin from its degradation products and excipients.
- 1 December 2009
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Journal of the Chilean Chemical Society
- Vol. 54 (4) , 424-427
Open AccessDETERMINATION OF GABAPENTIN IN BULK DRUG AND IN PHARMACEUTICAL DOSAGE FORM BY HPLC METHOD
This paper describes validation of the selective, precise and accurate isocratic HPLC method for the assay of Gabapentin as bulk and pharmaceutical dosage forms. The mobile phase composition was ammonium dihydrogen orthophosphate buffer and methanol in 60:40(v/v) proportions Column used was strong cation exchange column bonded with phenyl sulphonic acid. Quantitation was achieved by UV detection at 200 nm. A linear response (r² ≥ 0.999) was observed in the range of 2.5 mg/mL -7.5 mg/mL. The method shows good recoveries (Average 101.2%) and the relative standard deviation intra and inter-day were found to be less than 0.5 %. Validation parameters were also determined. The method can be used for quality control assay of Gabapentin as bulk and in fnished dosage form and for the stability studies as the method separates Gabapentin from its degradation products and excipients.
- 28 April 2009
- Published by Springer Nature in Chromatographia
- Vol. 70 (1) , 309-313
Stability-Indicating TLC Method for the Determination of Dutasteride in Pharmaceutical Dosage Forms
- 28 April 2009
- Published by Springer Nature in Chromatographia
- Vol. 70 (1) , 309-313
Stability-Indicating TLC Method for the Determination of Dutasteride in Pharmaceutical Dosage Forms
- 21 March 2009
- Published by Springer Nature in Chromatographia
- Vol. 69 (11-12) , 1463-1467
Stability-Indicating HPTLC Method for the Determination of Tamsulosin in Pharmaceutical Dosage Forms
- 21 March 2009
- Published by Springer Nature in Chromatographia
- Vol. 69 (11-12) , 1463-1467
Stability-Indicating HPTLC Method for the Determination of Tamsulosin in Pharmaceutical Dosage Forms